Darna LT, MB - financials and debts

Company age: 5 y. 6 mo.

Update

Darna LT - Company finances

EUR
2021
From: 2021-03-16
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 235 1,310 2,005 4,530 6,095
Profit before tax -39 106 - -215 545
Net profit -39 103 -410 -215 545
Equity 11 114 -467 -682 -137
Liabilities 12 26 473 847 330
Non-current assets 0 0 0 0 0
Current assets 23 140 6 165 193
Total assets 23 140 6 165 193
Taxes paid
STI taxes - - 3 135 -
Financial indicators
Revenue change y/y - +457.4% +53.1% +125.9% +34.5%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -169.6% 73.6% -6833.3% -130.3% 282.4%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. -354.5% 90.4% - - -
Profit margin Net profit margin. Shows the overall profitability of the company. -16.6% 7.9% -20.4% -4.7% 8.9%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. -16.6% 8.1% - -4.7% 8.9%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 1.1 0.2 - - -
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Darna LT - Social security debts

The company had no debts to Sodra

Darna LT - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Darna LT, MB (company code 305714888) is a small partnership engaged in physiotherapy activities. In 2025, the company generated EUR 6.1K in revenue, up 34.5% year on year and 204.0% over two years. After losses in 2023 and 2024, net profit turned positive in 2025 at EUR 545, resulting in an 8.9% profit margin. The trend over the last three years shows a gradual improvement from EUR 2.0K revenue and a EUR 410 loss in 2023, to EUR 4.5K revenue and a EUR 215 loss in 2024, and then to profitability in 2025. At the end of 2025, total assets stood at EUR 193, with equity at EUR -137 and liabilities at EUR 330. The balance sheet remains very small, and the reported return and leverage ratios are strongly affected by the limited asset and equity base. Asset turnover was 31.58x in 2025, reflecting high revenue relative to assets. No staff data is provided for revenue per employee analysis.